Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.56 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.56 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.56 |
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.54 |
| ▸ | HTR2C | P28335 | 1/20 | 0.54 |
| ▸ | PAM | P19021 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3692173 | 1.00 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL17212329 | 1.00 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL3815253 | 1.00 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL7879521 | 0.97 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL9355818 | 0.94 | DGKA (0.59) | DGKAMEN1KMT2APAMALDH1A1 | |
| SCHEMBL4340206 | 0.90 | DGKA (0.62) | DGKAMAPTDNM1LMNAMEN1 | |
| SCHEMBL3487129 | 0.90 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL294266 | 0.90 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL3487063 | 0.90 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL3813041 | 0.90 | DGKA (0.67) | DGKAMAPTPRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6767548-B2 | STABILIZED CONCENTRATES CONTAINING MICROBIOCIDESM MIXTURE OF OIL, CARDIIMIDE COMPOUND AND EMULSIFIER | ISP INVESTMENTS INC. | 2004-07-27 | — | — | US | disclosed |
| US-20030165554-A1 | Gel inhibited liquid carrier for a biocide containing a carbodiimide and an emulsifier mixture | ISP INVESTMENTS INC. | 2003-09-04 | — | — | US | disclosed |
| WO-2003069992-A1 | GEL INHIBITED LIQUID CARRIER FOR A BIOCIDE CONTAINING A CARBODIIMIDE AND AN EMULSIFIER MIXTURE | ISP INVESTMENTS INC. (US) | 2003-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030165554-A1 | Gel inhibited liquid carrier for a biocide containing a carbodiimide and an emulsifier mixture | HAO2, HAAO, ALOX12 | DGKA 931/4885MAPT 4792/4885PRSS1 4500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.